Package leaflet: Information for the patient Genticin 80mg/2ml Solution for Injection Gentamicin

Similar documents
PATIENT INFORMATION LEAFLET GENTAMICIN 10MG/ML SOLUTION FOR INJECTION OR INFUSION. and GENTAMICIN 40MG/ML SOLUTION FOR INJECTION OR INFUSION

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin

PACKAGE LEAFLET: INFORMATION FOR THE USER Gentamicin 40 mg/ml Injection

Amoxicillin 250mg Hard Capsules Amoxicillin 500mg Hard Capsules

PACKAGE LEAFLET Page 1 of 6

AMLODIPINE 5 MG TABLETS AMLODIPINE 10 MG TABLETS Amlodipine

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

Package leaflet: Information for the patient

Package leaflet: Information for the user. GENTAMICIN VISION 3 mg/ml eye drops, solution Gentamicin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 5 mg Tablets Amlodipine 10 mg Tablets (Amlodipine Besilate)

B. PACKAGE LEAFLET 1

2. What you need to know before you take Doxycycline capsule

Package leaflet: Information for the patient. Co-amoxiclav 250 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

New Zealand Consumer Medicine Information

Package leaflet: Information for the user. Amlodipin Aurobindo 10 mg tablets. Amlodipine

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)

PACKAGE LEAFLET: Information for the user. amlodipino cinfa 5 mg tablets

PACKAGE LEAFLET Page 1 of 7

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user

Package leaflet: Information for the user. Amlodipin Accord 10 mg tablets. Amlodipine

1. WHAT CO-AMOXICLAV TABLETS IS AND WHAT IT IS USED FOR

Health Products Regulatory Authority

Amlodipin Bluefish 10 mg tablets. amlodipine

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICATION PATIENT MEDICATION INFORMATION. Moxifloxacin tablets (as moxifloxacin hydrochloride)

Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg film-coated tablets. amoxicillin/ clavulanic acid

LABELLING AND PACKAGE LEAFLET

Amlodipine Pfizer 5 mg and 10 mg tablets Amlodipine

Package leaflet: Information for the patient. Desloratadine Cipla 5 mg film-coated tablets. Desloratadine

2 What you need to know before you take Augmentin

PACKAGE LEAFLET: INFORMATION FOR THE USER. GENTAMICIN VISION 3 mg/g eye ointment Gentamicin

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user Augmentin 875 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

B. PACKAGE LEAFLET 1

1 TRADE NAME OF THE MEDICINAL PRODUCT. Gentamicin Paediatric 20mg/2ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Package leaflet: Information for the patient. Germentin 500 mg/125 mg film coated tablets Amoxicillin/clavulanic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 10 mg Tablets. (Amlodipine Besilate)

PACKAGE LEAFLET: INFORMATION FOR THE USER

Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.

BIJSLUITER: INFORMATIE VOOR DE GEBRUIKER. Deslorasam 5 mg filmomhulde tabletten Desloratadine

Package leaflet: Information for the user

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

ANNEX III LABELLING AND PACKAGE LEAFLET

Package leaflet: Information for the patient. Amoxicilline/Clavulaanzuur Torrent 500 mg/125 mg filmomhulde tabletten. Amoxicillin Clavulanic acid

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Metacam 1.5 mg/ml oral suspension for dogs

Package leaflet: Information for the user. Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion Propofol

Package leaflet: Information for the user. AUGMENTIN DUO 400 mg/57 mg/5 ml powder for oral suspension Amoxicillin/clavulanic acid

NL/H/880/01-02 FINAL PL

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine maleate. Read all of this leaflet carefully before you start taking this medicine.

Summary of Product Characteristics

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

PACKAGE LEAFLET: INFORMATION FOR THE USER. Propofol 1% (10 mg/1 ml) Fresenius emulsion for injection or infusion Propofol

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

NL/H/882/ / Amlodipine CT 5 mg, tabletten Amlodipine CT 10 mg, tabletten

Day 90 Labelling, PL LABELLING AND PACKAGE LEAFLET

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

ANNEX III AMENDMENTS TO THE SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Minims Chloramphenicol

DEPO-MEDROL methylprednisolone acetate

1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

MEDICATION GUIDE FLOXIN [Flox in] (ofloxacin)

[09/2018] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

OFLOXACIN TABLETS MEDICATION GUIDE

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

Gentamicin or Tobramycin for Peritonitis in Peritoneal Dialysis

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/33

Summary of Product Characteristics

FDA-Approved Medication Guide MEDICATION GUIDE Moxifloxacin Hydrochloride Tablets (mox'' i flox' a sin hye'' droe klor' ide) Rx only

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user

Veterinary Medicinal Product

Package leaflet: Information for the user. Desloratadine Archie Samuel 5 mg filmomhulde tabletten Desloratadine

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. PATIENT MEDICATION INFORMATION HYDROmorphone Hydrochloride Injection USP

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (HYDROmorphone Hydrochloride) Sterile Solution for Injection

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. HYDROCORTISON CUM CHLORAMPHENICOL 5 mg/g + 2 mg/g eye ointment hydrocortisone acetate, chloramphenicol

Summary of Product Characteristics

DBL Doxycycline Doxycycline Hydrochloride (dox-i-sye-kleen)

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

VI.B.2 Elements for a public summary. VI.B.2.1 Overview of disease epidemiology

For a copy of a large print leaflet, Ph: Read this leaflet carefully before taking your medicine.

DBL GENTAMICIN INJECTION BP

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

AMLODIPINE GENERICHEALTH

Simplicef is Used to Treat Animals with Skin Infections

Transcription:

Package leaflet: Information for the patient Genticin 80mg/2ml Solution for Injection Gentamicin Read all of this leaflet carefully before you are given this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or nurse. If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. The name of your medicine is Genticin 80mg/2ml Solution for Injection it will be called Genticin Injection for ease here after. What is in this leaflet 1. What Genticin Injection is and what it is used for 2. What you need to know before you are given Genticin Injection 3. How you will be given Genticin Injection 4. Possible side effects 5. How to store Genticin Injection 6. Contents of the pack and other information 1. What Genticin Injection is and what is it used for The name of your medicine is Genticin Injection. This medicine contains the active ingredient gentamicin which belongs to a group of medicines called antibiotics. Genticin Injection is used in adults and children to treat bacterial infections such as severe chest infections, urinary tract infections and septicaemia. 2. What you need to know before you are given Genticin Injection You should not be given Genticin Injection: if you are allergic to gentamicin or to a similar medicine containing an aminoglycoside antibiotic or any of the other ingredients of this medicine (listed in section 6) if you suffer from myasthenia gravis (a disease causing muscle weakness). Warnings and precautions Talk to your doctor or nurse before you are given Genticin Injection: if you have any problems with your kidney or liver

if you have any problems with your hearing if you have any infections or a fever if you have low blood pressure or low blood volume if you are considered to be significantly overweight if you have Parkinson s Disease or any other disease causing muscle weakness if you are pregnant if you are taking medicines that may adversely affect the kidneys and hearing (i.e. cephaloridine and furosemide) as you should not take Genticin Injection for more than 7 days unless you have a severe and complicated infection. If any of these apply to you or if you are not sure tell your doctor. Monitoring tests Your doctor may want to send you for blood tests from time to time to check the levels of gentamicin in your blood. This is because your doctor may need to keep a careful eye on your treatment to prevent damage to your ears. Your doctor may also monitor your hearing, your balance and to assess how your kidneys and liver are working. Monitoring should occur before, after and during treatment with Genticin Injection. This monitoring applies to all patients, inclusive of adults, elderly, children and adolescents. (This also includes patients with kidney and/or liver disease and overweight patients). The dose of Genticin Injection that you will be given by the doctor or nurse will depend strictly on how well your kidneys are functioning. Other medicines and Genticin Injection Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines. This is especially important if you are taking: antibiotics such as penicillin, ticarcillin, clindamycin, lincomycin, cephalosporins (particularly cephaloridine), vancomycin or other aminoglycoside antibiotics (if taken with Genticin, this may adversely affect the kidneys and your hearing) ciclosporin (used to stop the body rejecting bone marrow or organ transplants) cisplatin and fludarabine (chemotherapy drugs) amphotericin (used to treat fungal infections) furosemide and piretanide (used as diuretics to treat heart problems) may increase the ear toxicity of gentamicin muscle relaxants medicines used to treat myasthenia gravis such as neostigmine and pyridostigmine

indomethacin (an anti-inflammatory) bisphosphonates (used to treat osteoporosis) oral anticoagulants (used to thin the blood) botulinum toxin (Botox) (used in cosmetic procedures or to reduce sweating) any medicines that can potentially cause kidney or hearing problems methoxyflurane (an anaesthetic gas), the Anaesthetist should know if you are receiving gentamicin before performing anaesthesia using methoxyflurane (type of gas that should be avoided to avoid kidney damage). If you are undergoing an operation, tell your anaesthetist if you have received or are receiving any other aminoglycoside-type antibiotics such as this medicine, before anaesthesia is administered. This will help your anaesthetist to choose the correct treatment for you. you will be monitored very carefully if you receive gentamicin before, during or after treatment with other medicinal products that may have possibly damaging effects on the ear nerve and kidneys. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before being given this medicine. Pregnancy Genticin Injection is not recommended for use in pregnancy unless considered appropriate by your doctor. Breast-feeding Breast-feeding is not recommended whilst using Genticin Injection if you are suffering from kidney problems. Gentamicin is released into the breast milk. Diarrhoea and fungal infection of the mouth may occur in the breast-fed infant whilst the mother is being treated with this antibiotic. It is advised that breast-feeding is stopped and an alternative feeding program (i.e. formula bottle fed) is given to your child during treatment with this antibiotic. Your baby may develop an allergic reaction if it is continued to be breast-fed whilst mother is receiving Genticin Injection. Driving and using machines Caution is advised when driving and using machines in view of the possible undesired effects such as dizziness and vertigo.

3. How you will be given Genticin Injection The medicine will be given to you by a doctor or nurse as an injection into the muscle (i/m) or vein (i/v), it can also be given as a drip (infusion). Your doctor will work out the dose which is suitable for you. Your blood levels of the gentamicin will be carefully monitored by the doctor or nurse examining blood samples taken at the end of a dosage interval and immediately after the end of the infusion, mainly in order to control your kidney function. Your dose will carefully be adjusted in order to avoid kidney damage. Your treatment with gentamicin will not last longer than 7 days unless you have a severe and complicated infection. The recommended dose in children, adolescents and adults with normal kidney function is 3-6 mg/kg of body weight per day as 1 (preferred) up to 2 single doses. In life-threatening infections, the frequency of dosage or total dosage may need to be increased by your doctor. Use in infants after the first month of life The daily dose in infants after the first month of life is 4.5-7.5 mg/kg of body weight per day as one (preferred) up to two single doses. Use in newborns The daily dose in newborns is 4-7 mg/kg of body weight per day. Due to the longer half-life, newborns are given the required daily dose in one single dose. Use in patients with kidney problems Caution must be taken regarding dosage. Your doctor or nurse will calculate the amount of medicine you should receive. Patients receiving kidney dialysis Caution must be taken regarding dosage. Your doctor or nurse will calculate the amount of medicine you should receive. Use in patients with liver problems Caution must be taken regarding dosage. Your doctor or nurse will calculate the amount of medicine you should receive. Use in elderly patients The dose for the elderly will be adjusted accordingly. Use in overweight patients The dosage of medicine will be adjusted to compensate for the body weight.

If you are given more Genticin injection than you should At first treatment will be stopped, there is no specific antidote. Overdosing is likely. If it does happen, the doctor will treat any symptoms that follow. Symptoms of overdose include feelings of dizziness or a spinning sensation and hearing loss. Inform your doctor or nurse if you experience these side effects soon after being given Genticin Injection. Gentamicin can be removed from the blood by kidney dialysis. If you have any further questions on the use of this medicine, ask your doctor or nurse. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Under certain conditions, gentamicin shows toxic effects on the ear nerve and kidneys. Kidney damage is commonly observed in patients treated with gentamicin and will usually resolve after withdrawal of the drug. In most cases, kidney toxicity is associated with an excessively high dosage or long lasting treatment, already existing kidney abnormalities or is associated with other substances also having a toxic effect on kidneys. Additional risk factors for kidney toxicity are advanced age, low blood pressure, decreased blood volume or shock or existing liver disease. Risk factors for toxic effects on the ear nerve are existing liver or hearing impairment, bacteria in the blood and fever. If you notice: itching or skin rashes, hives (urticaria), that can be signs of severe acute hypersensitivity (allergic) reactions swelling of the face, lips or throat difficulty in breathing or wheeziness. If you experience these side effects after surgery, this may be due to the medicine affecting your breathing decreased amount of urine or complete urination stop (oliguria, anuria), excessive urination at night and generalized swelling (fluid retention) are signs of acute kidney failure. Tell your doctor immediately. These may be signs of an allergic reaction. Common (may affect up to 1 in 10 people): kidney function impairment (usually resolving after stop of treatment) problems with your kidney function difficulty in breathing following surgery

pseudomembranous colitis (inflammation of the intestines due to antibiotics, also known as antibiotic associated diarrhoea characterised by diarrhoea, abdominal pain and fever). Uncommon (may affect up to 1 in 100 people): sore mouth problems with your liver blood disorders such pancytopenia (low levels of white and red blood cell) anaemia (reduction in red blood cells which can make the skin pale and cause weakness or breathlessness). Rare (may affect up to 1 in 1,000 people): diarrhoea being sick (vomiting), Feeling sick (nausea) increased saliva muscle pain (myalgia) stomach pain electrolyte disturbances (changes in the levels of salts such as magnesium, calcium and potassium in the blood) impairment or loss of hearing and ringing in the ears (tinnitus). In some cases hearing loss is irreversible. changes in liver function (indicated by change in your liver enzymes) loss of appetite, weight loss. Very Rare (may affect up to 1 in 10,000 people): problems with your brain (brain disease) convulsions blockage of nerve and muscle function dizziness infection with other gentamicin-resistant germs, large bowel inflammation (may be due to other antibiotics) abnormally low counts of different blood cell types, increased count of eosinophils (a certain group of white blood cells). Leukopenia, granulocytopenia, neutropenia (low white blood cell counts), thrombocytopenia (reduction in platelet count), reticulocytopenia (abnormal decrease of reticulocytes in the body, which are immature red blood cells.) fits, confusion, hallucinations, tiredness and depression high blood pressure low blood pressure drug fever problems with your vision

pain at the site where injection is given muscle tremor (causing difficulty in standing) hair loss headache acute kidney failure high urine levels of phosphate and amino acids (so called Fanconi-like syndrome, associated with high doses given over long time). Not known (frequency cannot be estimated from the available data): symptoms of bruising, discolouration of skin, small red spots. These could be a sign of purpura rash pruritus irreversible hearing loss, deafness. Reporting of side effects If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via: HPRA Pharmacovigilance Earlsfort Terrace IRL Dublin 2 Ireland Tel: +353 1 676 4971 Fax: +353 1 676 2517 Website: www.hpra.ie Email: medsafety@hpra.ie By reporting side effects, you can help provide more information on the safety of this medicine. 5. How to store Genticin Injection Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month. Do not store above 25 C. Do not freeze. For single use only. Discard any portion of the contents remaining after use.

Do not use this medicine if you notice that the solution is no longer colourless to pale yellow or contains visible particulates. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Genticin Injection contains -The active substance is gentamicin sulphate. Each 2 ml ampoule contains gentamicin sulphate (equivalent to 80mg gentamicin base). - The other ingredients are water for injection and sulphuric acid. What Genticin Injection looks like and the content of the pack Genticin Injection is a clear colourless solution. It is available in 2ml clear glass ampoules in boxes of 10 x 2ml ampoules. Marketing Authorisation Holder Amdipharm UK Limited Capital House 85 King William Street London EC4N 7BL. UK Manufacturer Farmar S.A. Agiou Dimitriou 63, Alimos Attiki, 17456 Greece This leaflet was last revised in March 2018. Genticin is a registered trademark of Amdipharm International Limited.